$316.42

+0.29 (+0.09%)

Weekly Expected Move ±7.7%

$256 $280 $303 $326 $349

NYSE · Healthcare · Medical - Instruments & Supplies · Alpha Radar Buy · Power 68 · $22.4B mcap · 70M float · 1.27% daily turnover · Short 63% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$3.1B +6.3% ▲

5Y CAGR: +7.4%

Gross Profit

$1.1B +10.1% ▲

5Y CAGR: +7.5%

Operating Income

$617M +3.8% ▲

5Y CAGR: +8.1%

Net Income

$494M +0.2% ▲

5Y CAGR: +7.4%

EPS (Diluted)

$6.80 +1.6% ▲

5Y CAGR: +8.3%

EBITDA

$724M -2.7% ▼

5Y CAGR: +6.9%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$2.8B	$2.9B	$3.0B	$2.9B	$3.1B
YoY Growth	+31.9%	+1.9%	+2.3%	-2.0%	+6.3%
Cost of Revenue	$1.7B	$1.7B	$1.8B	$1.9B	$2.0B
Gross Profit	$1.2B	$1.1B	$1.1B	$1.0B	$1.1B
Gross Margin	41.5%	39.5%	38.4%	34.6%	35.9%
R&D Expenses	$53M	$58M	$68M	$69M	$74M
SG&A Expenses	$362M	$317M	$353M	$338M	$393M
Operating Expenses	$415M	$375M	$422M	$408M	$486M
Operating Income	$759M	$764M	$711M	$595M	$617M
Operating Margin	26.8%	26.5%	24.1%	20.6%	20.1%
Interest Expense	$8M	$8M	$9M	$3M	$600K
Income Before Tax	$769M	$701M	$716M	$600M	$615M
Tax Expense	$107M	$115M	$122M	$108M	$122M
Net Income	$662M	$586M	$593M	$493M	$494M
Net Margin	23.4%	20.3%	20.1%	17.0%	16.1%
EPS (Diluted)	$8.67	$7.73	$7.88	$6.69	$6.80
EBITDA	$880M	$808M	$844M	$744M	$724M
Shares Outstanding	76M	76M	75M	74M	73M

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$702M	$747M	$748M	$698M	$766M	$804M	$805M	$845M
Cost of Revenue	$471M	$482M	$474M	$466M	$493M	$511M	$501M	$548M
Gross Profit	$231M	$265M	$274M	$233M	$273M	$294M	$304M	$296M
Gross Margin	32.9%	35.5%	36.7%	33.3%	35.7%	36.5%	37.8%	35.1%
R&D Expenses	$18M	$16M	$18M	$16M	$19M	$17M	$22M	$16M
SG&A Expenses	$83M	$82M	$85M	$88M	$96M	$103M	$106M	$100M
Operating Expenses	$100M	$97M	$104M	$104M	$115M	$120M	$147M	$119M
Operating Income	$131M	$168M	$171M	$128M	$158M	$174M	$157M	$177M
Operating Margin	18.6%	22.5%	22.8%	18.4%	20.6%	21.6%	19.5%	21.0%
Interest Expense	$2M	$700K	$0	$400K	$100K	$100K	$0	$0
Income Before Tax	$133M	$168M	$167M	$114M	$162M	$174M	$165M	$180M
Tax Expense	$22M	$32M	$37M	$24M	$30M	$34M	$33M	$45M
Net Income	$111M	$136M	$130M	$90M	$132M	$140M	$132M	$139M
Net Margin	15.9%	18.2%	17.4%	12.9%	17.2%	17.4%	16.4%	16.4%
EPS (Diluted)	$1.51	$1.85	$1.78	$1.23	$1.82	$1.93	$1.82	$1.92
EBITDA	$169M	$205M	$206M	$151M	$198M	$217M	$210M	$174M
Shares Outstanding	74M	73M	74M	73M	73M	73M	73M	72M

WST NYSE